Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma [Phase 1]
Phase 1 study evaluating the safety and preliminary efficacy of combining axicabtagene ciloleucel with utomilumab in adults with relapsed/re…
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma [Phase 1]
Phase 1 clinical trial examining lenzilumab in combination with axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma was …
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma [Phase 2]
Phase 2 study evaluating axicabtagene ciloleucel in combination with rituximab for refractory large B-cell lymphoma has completed with resul…
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma [Phase 2]
A Phase 2 clinical trial update evaluating Relmacabtagene Autoleucel as first-line therapy for high-risk large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Study of Efficacy of BZ019 in Large B-cell Lymphoma [Phase 2]
Phase 2 clinical trial update for BZ019 in Large B-cell Lymphoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2022-01-28New gene therapy treatment for patients with relapsed or refractory large B-cell lymphoma
The EMA announces a new gene therapy for patients with relapsed or refractory large B-cell lymphoma, representing a pivotal development in t…
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Lenalidomide and R-CHOP in B-cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial updating the combination of lenalidomide with R-CHOP in various B-cell lymphomas; study completed.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and tolerability of HSC835 in patients with various hematologic malignancies completed with results posted …